Genetically engineered yeast makes medicinal plant products

José Montaño López; José L. Avalos

doi:10.1038/d41586-020-02461-8

Genetically engineered yeast makes medicinal plant products

José Montaño López, José L. Avalos

Research output: Contribution to journal › Comment/debate › peer-review

2 Scopus citations

Abstract

Yeast has been engineered to convert simple sugars and amino acids into drugs that inhibit a neurotransmitter molecule. The work marks a step towards making the production of these drugs more reliable and sustainable.

Original language	English (US)
Pages (from-to)	504-505
Number of pages	2
Journal	Nature
Volume	585
Issue number	7826
DOIs	https://doi.org/10.1038/d41586-020-02461-8
State	Published - Sep 24 2020

All Science Journal Classification (ASJC) codes

General

Keywords

Biotechnology
Microbiology
Synthetic biology

Access to Document

10.1038/d41586-020-02461-8

Cite this

@article{dd76aaa915c444c2a530f6c5e30d1bfc,

title = "Genetically engineered yeast makes medicinal plant products",

abstract = "Yeast has been engineered to convert simple sugars and amino acids into drugs that inhibit a neurotransmitter molecule. The work marks a step towards making the production of these drugs more reliable and sustainable.",

keywords = "Biotechnology, Microbiology, Synthetic biology",

author = "{Monta{\~n}o L{\'o}pez}, Jos{\'e} and Avalos, {Jos{\'e} L.}",

note = "Publisher Copyright: {\textcopyright} Springer Nature Limited 2020.",

year = "2020",

month = sep,

day = "24",

doi = "10.1038/d41586-020-02461-8",

language = "English (US)",

volume = "585",

pages = "504--505",

journal = "Nature",

issn = "0028-0836",

publisher = "Nature Research",

number = "7826",

}

TY - JOUR

T1 - Genetically engineered yeast makes medicinal plant products

AU - Montaño López, José

AU - Avalos, José L.

N1 - Publisher Copyright: © Springer Nature Limited 2020.

PY - 2020/9/24

Y1 - 2020/9/24

N2 - Yeast has been engineered to convert simple sugars and amino acids into drugs that inhibit a neurotransmitter molecule. The work marks a step towards making the production of these drugs more reliable and sustainable.

AB - Yeast has been engineered to convert simple sugars and amino acids into drugs that inhibit a neurotransmitter molecule. The work marks a step towards making the production of these drugs more reliable and sustainable.

KW - Biotechnology

KW - Microbiology

KW - Synthetic biology

UR - http://www.scopus.com/inward/record.url?scp=85091578068&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85091578068&partnerID=8YFLogxK

U2 - 10.1038/d41586-020-02461-8

DO - 10.1038/d41586-020-02461-8

M3 - Comment/debate

C2 - 32879477

AN - SCOPUS:85091578068

SN - 0028-0836

VL - 585

SP - 504

EP - 505

JO - Nature

JF - Nature

IS - 7826

ER -

Genetically engineered yeast makes medicinal plant products

Abstract

All Science Journal Classification (ASJC) codes

Keywords

Access to Document

Other files and links

Fingerprint

Cite this